Bioasis Technologies (Bioasis Technologies) Days Sales Outstanding

: 9.86 (As of Nov. 2022)

View and export this data going back to 2009. Start your Free Trial

Bioasis Technologies's average Accounts Receivable for the three months ended in Nov. 2022 was $0.01 Mil. Bioasis Technologies's Revenue for the three months ended in Nov. 2022 was $0.11 Mil. Hence, Bioasis Technologies's Days Sales Outstanding for the three months ended in Nov. 2022 was 9.86.

The historical rank and industry rank for Bioasis Technologies's Days Sales Outstanding or its related term are showing as below:

BIOAF's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.545
* Ranked among companies with meaningful Days Sales Outstanding only.

Bioasis Technologies's Days Sales Outstanding declined from Nov. 2021 (130.79) to Nov. 2022 (9.86).

Bioasis Technologies Days Sales Outstanding Historical Data

The historical data trend for Bioasis Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Days Sales Outstanding

21.01

4.58

7.20

1.93

614.42

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Days Sales Outstanding																130.79	-	-	73.10	9.86

Competitive Comparison

For the Biotechnology subindustry, Bioasis Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies Days Sales Outstanding Distribution

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's Days Sales Outstanding falls into.

Bioasis Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bioasis Technologies's Days Sales Outstanding for the fiscal year that ended in Feb. 2022 is calculated as

	Days Sales Outstanding (A: Feb. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Feb. 2021 )	+	Accounts Receivable (A: Feb. 2022 ))	/	count )	/	Revenue (A: Feb. 2022 )	*	Days in Period
=	( (0.024	+	0.077)	/	2 )	/	0.03	*	365
=	0.0505					/	0.03	*	365
=	614.42

Bioasis Technologies's Days Sales Outstanding for the quarter that ended in Nov. 2022 is calculated as:

	Days Sales Outstanding (Q: Nov. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Aug. 2022 )	+	Accounts Receivable (A: Nov. 2022 ))	/	count )	/	Revenue (A: Nov. 2022 )	*	Days in Period
=	( (0.014	+	0.01)	/	2 )	/	0.111	*	365 / 4
=	0.012					/	0.111	*	365 / 4
=	9.86

Bioasis Technologies (OTCPK:BIOAF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Bioasis Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies (Bioasis Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (OTCPK:BIOAF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.